Summit Therapeutics (NASDAQ:SMMT) will release its quarterly earnings report on Monday, 2026-02-23. Here’s a brief overview for investors ahead of the announcement.
Analysts anticipate Summit Therapeutics to report an earnings per share (EPS) of $-0.11.
Investors in Summit Therapeutics are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Historical Earnings Performance
In the previous earnings release, the company missed …